KIORA PHARMACEUTICALS
- Pharmaceutical Preparations
- Encinitas, California
Compensation history
Top executives at KIORA PHARMACEUTICALS received an average of $515K per person in annual compensation from 2014 to 2023.
Average pay of disclosed executives at KIORA PHARMACEUTICALS
By year
- 2022
BS$714KBrian M. StremPresident and Chief Executive OfficerED$547KEric J. DanielsChief Development OfficerSF$382KStephen FromFormer Executive Chairman; former President and Chief Executive OfficerSR$171KSarah RomanoFormer Chief Financial OfficerMT$133KMelissa ToscaExecutive Vice President of Finance- 2021
FO$581KFranz ObermayrFormer Acting Chief Executive Officer; former EVP Clinical DevelopmentSF$572KStephen FromFormer Executive Chairman; former President and Chief Executive OfficerSR$554KSarah RomanoFormer Chief Financial OfficerBS$444KBrian M. StremPresident and Chief Executive OfficerED$156KEric J. DanielsChief Development Officer
Executives
We found eight executives who work or worked at KIORA PHARMACEUTICALS.
Brian Strem
KIORA PHARMACEUTICALS
Chief Executive Officer
Eric Daniels
KIORA PHARMACEUTICALS
Chief Development Officer
Melissa Tosca
KIORA PHARMACEUTICALS
Executive Vice President of Finance
Stephen From
KIORA PHARMACEUTICALS
Chief Executive Officer
Sarah Romano
KIORA PHARMACEUTICALS
Chief Financial Officer
Franz Obermayr
KIORA PHARMACEUTICALS
Chief Executive Officer
Michael Manzo
KIORA PHARMACEUTICALS
Vice President of Engineering
Barbara Wirostko
KIORA PHARMACEUTICALS
Chief Medical Officer
News
KIORA PHARMACEUTICALS CEO Brian Strem's 2023 pay rises 12% to $802K
March 25, 2024
KIORA PHARMACEUTICALS CEO Brian Strem's 2022 pay jumps 61% to $714K
April 28, 2023
KIORA PHARMACEUTICALS CEO Franz Obermayr's 2021 pay jumps 6,760% to $581K
August 15, 2022
KIORA PHARMACEUTICALS CEO Stephen From's 2019 pay falls 40% to $601K
April 29, 2020
KIORA PHARMACEUTICALS CEO Stephen From's 2018 pay rises 14% to $1,000K
April 30, 2019
About KIORA PHARMACEUTICALS
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryPharmaceutical Preparations
- Address332 Encinitas Boulevard, Suite 102, Encinitas, California 92024
- Phone781-788-8869
- Fiscal year endDecember 31
- Former names
- EYEGATE PHARMACEUTICALS INCUntil November 3, 2021
Source: SEC filings on March 25, 2024, July 21, 2023, August 15, 2022, April 29, 2020, April 30, 2019, May 29, 2018, April 28, 2017, and April 28, 2016.